VariSeed 7.0 Treatment Planning Tool for Permanent Seed Implant Brachytherapy

Oncology NEWS InternationalOncology NEWS International Vol 11 No 5
Volume 11
Issue 5

PALO ALTO, California-Varian Medical Systems has released VariSeed 7.0, the company’s newest treatment planning software for permanent seed implant brachytherapy used in treating prostate cancer. VariSeed 7.0 gives physicians the ability to use real-time images generated during the implant procedure to deliver precise accurate doses, the company said in a news release.

PALO ALTO, California—Varian Medical Systems has released VariSeed 7.0, the company’s newest treatment planning software for permanent seed implant brachytherapy used in treating prostate cancer. VariSeed 7.0 gives physicians the ability to use real-time images generated during the implant procedure to deliver precise accurate doses, the company said in a news release.

Using VariSeed 7.0, radiation oncologists can generate a treatment plan, use it to implant the seeds, and see how the radiation dose will develop within the patient’s anatomy while the patient is still in the operating room. This allows for fine-tuning and more precise adjustments on the spot, the company said.

VariSeed 7.0 also introduces the ability to superimpose different kinds of diagnostic images such as MRI and single photon emission computed tomography (SPECT), which show the extent of disease, with CT and ultrasound images, which show anatomy and positioning. This enables physicians to adjust implants according to an individual patient’s disease characteristics.

VariSeed 7.0 is now available to new customers and as a software upgrade to clinics that already use VariSeed for planning and documenting prostate seed implant dosimetry.

Related Videos
Andrew J. Armstrong, MD, MSc, spoke about the recent approval of olaparib plus abiraterone acetate and prednisone in patients with BRCA-mutant metastatic castration-resistant prostate cancer.
Expert on prostate cancer
Expert on prostate cancer
Experts on prostate cancer
Expert on prostate cancer
Expert on prostate cancer
Expert on prostate cancer
Experts on prostate cancer
Experts on prostate cancer
Title Card - Understanding and Mitigating the Cardiometabolic Risks of ADT
Related Content